Literature DB >> 33098202

Model-dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma.

Gennie L Parkman1,2, David A Kircher2,3, Christopher M Stehn2, Martin McMahon1,2,4, Sheri L Holmen1,2,3.   

Abstract

Entities:  

Keywords:  melanoma; mouse models; sex as a biological variable

Mesh：

Substances：

Year:  2020        PMID： 33098202      PMCID： PMC8052264          DOI： 10.1111/pcmr.12940

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  14 in total

1.  AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.

Authors:  David A Kircher; Kirby A Trombetti; Mark R Silvis; Gennie L Parkman; Grant M Fischer; Stephanie N Angel; Christopher M Stehn; Sean C Strain; Allie H Grossmann; Keith L Duffy; Kenneth M Boucher; Martin McMahon; Michael A Davies; Michelle C Mendoza; Matthew W VanBrocklin; Sheri L Holmen
Journal:  Mol Cancer Res       Date:  2019-05-28       Impact factor: 5.852

2.  Differences in tumor initiation and progression of melanoma in the BrafCA ;Tyr-CreERT2;Ptenf/f model between male and female mice.

Authors:  Yougang Zhai; Adil J Haresi; Lee Huang; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2019-09-10       Impact factor: 4.693

3.  Tyrosinase-related protein 2 promoter targets transgene expression to ocular and neural crest-derived tissues.

Authors:  S Zhao; P A Overbeek
Journal:  Dev Biol       Date:  1999-12-01       Impact factor: 3.582

4.  Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female mice.

Authors:  Lucas L Falke; Roel Broekhuizen; Alwin Huitema; Erik Maarseveen; Tri Q Nguyen; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2017-05-11       Impact factor: 5.782

5.  Estrogen receptor alpha expression in mice kidney shows sex differences during aging.

Authors:  P K Sharma; M K Thakur
Journal:  Biogerontology       Date:  2004       Impact factor: 4.277

6.  Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.

Authors:  Jennifer Tsoi; Lidia Robert; Kim Paraiso; Carlos Galvan; Katherine M Sheu; Johnson Lay; Deborah J L Wong; Mohammad Atefi; Roksana Shirazi; Xiaoyan Wang; Daniel Braas; Catherine S Grasso; Nicolaos Palaskas; Antoni Ribas; Thomas G Graeber
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 38.585

7.  Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model.

Authors:  Mihaela Surcel; Carolina Constantin; Constantin Caruntu; Sabina Zurac; Monica Neagu
Journal:  J Immunol Res       Date:  2017-11-26       Impact factor: 4.818

8.  Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor.

Authors:  Ernesto Cortes; Dariusz Lachowski; Alistair Rice; Stephen D Thorpe; Benjamin Robinson; Gulcen Yeldag; David A Lee; Leo Ghemtio; Krista Rombouts; Armando E Del Río Hernández
Journal:  Oncogene       Date:  2018-12-21       Impact factor: 9.867

9.  Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade.

Authors:  Christopher A Natale; Jinyang Li; Junqian Zhang; Ankit Dahal; Tzvete Dentchev; Ben Z Stanger; Todd W Ridky
Journal:  Elife       Date:  2018-01-16       Impact factor: 8.140

10.  Why do women with melanoma do better than men?

Authors:  Keiran Sm Smalley
Journal:  Elife       Date:  2018-01-16       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.